DETERMINATION OF IMMUNITY TO MEASLES-VIRUS IN YOUNG-ADULTS - COMPARATIVE-EVALUATION OF A COMMERCIAL ENZYME-IMMUNOASSAY AND THE HEMAGGLUTINATION INHIBITION TECHNIQUES
P. Duvdevani et al., DETERMINATION OF IMMUNITY TO MEASLES-VIRUS IN YOUNG-ADULTS - COMPARATIVE-EVALUATION OF A COMMERCIAL ENZYME-IMMUNOASSAY AND THE HEMAGGLUTINATION INHIBITION TECHNIQUES, Clinical and diagnostic virology, 7(1), 1996, pp. 1-6
Background: Determination of the immune status against measles in youn
g adults requires careful evaluation of the laboratory methods because
of waning immunity. The hemagglutination inhibition (HI) test and enz
yme-linked immunosorbent assay (ELISA) may lack the sensitivity requir
ed to detect very low levels of antibodies. In addition, the correlati
on between ELISA-IgG assays and the degree of protection from measles
is not well defined. Objectives: (a) Evaluation of a commonly used mea
sles ELISA-IgG test kit in comparison with the hemagglutination inhibi
tion (HI) test which corresponds strongly to virus neutralization; (b)
determination of false negative rates of the ELISA-IgG and the HI tes
ts; (c) evaluation of the ELISA-IgG test kit as a quantitative assay.
Study design: One hundred and eighty serum samples collected from 60 v
accinated young adults immediately before vaccination and 14 and 28 da
ys postvaccination, were tested comparatively by HI and by a commercia
l ELISA-IgG kit. For evaluation of false negative rates, postvaccinati
on sera of a cohort of 48 vaccinees with negative HI or ELISA-IgG prev
accination sera were tested for IgM. Sixty-three of the samples were a
lso titrated by the ELISA-IgG kit using serial dilutions, for comparis
on with HI titers. Results: Using the HI test as a reference method, t
he ELISA-IgG kit was found to have overall accuracy of 81%, sensitivit
y of 80% and specificity of 84%. The false negative and the false posi
tive rates were 20% and 16%, respectively. In contrast, when we used p
ostvaccination IgM test to distinguish between true and false prevacci
nation negatives in both the HI and ELISA-IgG tests, we found that the
false negative rates were 75.6% by ELISA and 72.5% by HI, and the fal
se positive rates were 2.4% and 0%, respectively. Serum titers determi
ned by the ELISA-IgG test were generally 5-10-fold higher than the cor
responding HI titers, but without a consistent correlation. Conclusion
s: Both the ELISA-IgG and the HI tests frequently failed to detect res
idual immunity. The two tests also did not correlate well with each ot
her suggesting that different antigenic determinants of the virus are
involved in each assay and therefore the HI test should not be used as
a reference method for evaluation of the sensitivity of ELISA IgG kit
s.